• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Inequities in lung cancer treatment: lessons from international variation in chemotherapy and radiotherapy use.

作者信息

O'Dowd Emma L, Callister Matthew Ej

机构信息

Centre for Cancer Sciences, University of Nottingham, Nottingham, England, UK.

Department of Respiratory Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, England, UK.

出版信息

BMJ Oncol. 2025 Aug 28;4(1):e000877. doi: 10.1136/bmjonc-2025-000877. eCollection 2025.

DOI:10.1136/bmjonc-2025-000877
PMID:40909187
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12406937/
Abstract
摘要

相似文献

1
Inequities in lung cancer treatment: lessons from international variation in chemotherapy and radiotherapy use.肺癌治疗中的不平等：化疗和放疗使用的国际差异带来的启示。
BMJ Oncol. 2025 Aug 28;4(1):e000877. doi: 10.1136/bmjonc-2025-000877. eCollection 2025.
2
Chemotherapy and radiotherapy use in patients with lung cancer in Australia, Canada, the UK and Norway 2012-2017: an ICBP population-based study.2012 - 2017年澳大利亚、加拿大、英国和挪威肺癌患者的化疗和放疗使用情况：一项基于国际癌症基准伙伴关系（ICBP）人群的研究
BMJ Oncol. 2025 Jul 11;4(1):e000800. doi: 10.1136/bmjonc-2025-000800. eCollection 2025.
3
Chemotherapy for non-small cell lung cancer.非小细胞肺癌的化疗
Cochrane Database Syst Rev. 2000;2000(2):CD002139. doi: 10.1002/14651858.CD002139.
4
Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.针对非小细胞肺癌引起胸部症状患者的姑息性放疗方案。
Cochrane Database Syst Rev. 2015 Jan 14;1(1):CD002143. doi: 10.1002/14651858.CD002143.pub4.
5
Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation.厄洛替尼和吉非替尼用于治疗先前化疗后进展的非小细胞肺癌（英国国家卫生与临床优化研究所技术评估162和175回顾）：一项系统评价与经济学评估
Health Technol Assess. 2015 Jun;19(47):1-134. doi: 10.3310/hta19470.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer.早期非小细胞肺癌切除术后的辅助化疗
Cochrane Database Syst Rev. 2015 Mar 2;2015(3):CD011430. doi: 10.1002/14651858.CD011430.
8
Immune checkpoint inhibitors plus platinum-based chemotherapy compared to platinum-based chemotherapy with or without bevacizumab for first-line treatment of older people with advanced non-small cell lung cancer.免疫检查点抑制剂联合铂类化疗对比铂类化疗联合或不联合贝伐珠单抗用于治疗老年人晚期非小细胞肺癌的一线治疗。
Cochrane Database Syst Rev. 2024 Aug 13;8(8):CD015495. doi: 10.1002/14651858.CD015495.
9
Concurrent chemoradiotherapy in non-small cell lung cancer.非小细胞肺癌的同步放化疗
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002140. doi: 10.1002/14651858.CD002140.pub2.
10
Surgery for limited-stage small-cell lung cancer.局限期小细胞肺癌的手术治疗
Cochrane Database Syst Rev. 2017 Apr 21;4(4):CD011917. doi: 10.1002/14651858.CD011917.pub2.

本文引用的文献

1
Chemotherapy and radiotherapy use in patients with lung cancer in Australia, Canada, the UK and Norway 2012-2017: an ICBP population-based study.2012 - 2017年澳大利亚、加拿大、英国和挪威肺癌患者的化疗和放疗使用情况：一项基于国际癌症基准伙伴关系（ICBP）人群的研究
BMJ Oncol. 2025 Jul 11;4(1):e000800. doi: 10.1136/bmjonc-2025-000800. eCollection 2025.
2
"The challenge is the complexity" - A qualitative study about decision-making in advanced lung cancer treatment.“挑战在于复杂性”——一项关于晚期肺癌治疗决策的定性研究。
Lung Cancer. 2023 Sep;183:107312. doi: 10.1016/j.lungcan.2023.107312. Epub 2023 Jul 20.
3
Novel Targets, Novel Treatments: The Changing Landscape of Non-Small Cell Lung Cancer.新型靶点与新型疗法：非小细胞肺癌不断变化的格局
Cancers (Basel). 2023 May 21;15(10):2855. doi: 10.3390/cancers15102855.
4
Chemotherapy decision-making in advanced lung cancer: a prospective qualitative study.晚期肺癌的化疗决策：一项前瞻性定性研究。
BMJ Support Palliat Care. 2020 Aug 21. doi: 10.1136/bmjspcare-2020-002395.
5
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.1995-2014 年七个高收入国家癌症存活率、死亡率和发病率的进展（ICBP SURVMARK-2）：一项基于人群的研究。
Lancet Oncol. 2019 Nov;20(11):1493-1505. doi: 10.1016/S1470-2045(19)30456-5. Epub 2019 Sep 11.
6
Real-world data: towards achieving the achievable in cancer care.真实世界数据：在癌症治疗中实现可实现的目标。
Nat Rev Clin Oncol. 2019 May;16(5):312-325. doi: 10.1038/s41571-019-0167-7.
7
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology Summary.老年化疗患者脆弱性的实践评估与管理：美国临床肿瘤学会老年肿瘤学指南总结
J Oncol Pract. 2018 Jul;14(7):442-446. doi: 10.1200/JOP.18.00180. Epub 2018 Jun 22.
8
EORTC elderly task force position paper: approach to the older cancer patient.EORTC 老年肿瘤专家组立场文件：老年癌症患者处理方法。
Eur J Cancer. 2010 Jun;46(9):1502-13. doi: 10.1016/j.ejca.2010.02.022. Epub 2010 Mar 12.